Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2025-07-17T13:05:48.791960Z
Market Cap
16.43M

Momentum Score

…

Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.03
Low
0.08
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.15M
Revenue Per Share
0.00
Gross Profit TTM
-0.78M
Debt / Equity
-
ROE
-2802.21%
Net Debt
0.74M
ROCE
-77.81%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -4.26M -5.57M -5.90M -1.85M -5.77M
Net income -4.29M -5.71M -5.95M -7.08M -5.77M
Selling general administrative 2.64M 2.84M 4.66M 1.88M 5.51M
Selling and marketing expenses 1.13M - - - -
Gross profit -0.21M -0.78M -0.04M 0.04M 0.69M
Reconciled depreciation 0.13M 0.11M 0.02M 0.33M 0.32M
Ebit -3.94M -5.57M -4.80M -2.95M -3.22M
Ebitda -3.81M -5.46M -4.78M -2.62M -2.89M
Depreciation and amortization 0.13M 0.11M 0.02M 0.33M 0.32M
Operating income -4.12M -5.57M -5.90M -1.85M -4.50M
Other operating expenses 4.20M 6.20M 6.22M 1.94M 5.51M
Interest expense 0.32M 0.00M 0.00M 0.00M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.02M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.30M 0.00M 0.00M 0.00M 0.00M
Income tax expense 0.20M 0.14M 0.05M 5.23M 1.28M
Total revenue 0.08M 0.62M 0.32M 0.09M 1.02M
Total operating expenses 3.91M 4.80M 5.86M 1.88M 5.51M
Cost of revenue 0.29M 1.40M 0.36M 0.06M 0.32M
Total other income expense net -0.15M 0.00M 0.00M 1.10M -1.28M
Discontinued operations -0.02M -0.14M -0.05M -5.23M -5.14M
Net income from continuing ops -4.26M -5.57M -4.80M -1.85M -5.77M
Net income applicable to common shares - -5.71M -4.85M -8.18M -5.77M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 6.14M 3.26M 1.76M 3.34M 7.63M
Intangible assets 1.21M 1.19M - - 0.44M
Other current assets - - - 0.30M -
Total liab 5.26M 1.72M 1.99M 1.23M 1.31M
Total stockholder equity 0.88M 1.54M -0.22M 2.11M 6.32M
Other current liab - 0.61M 1.20M - -
Common stock 2.61M 2.12M 2.02M 1.73M 1.36M
Capital stock 2.61M 2.12M 2.02M 1.73M 1.36M
Retained earnings -18.91M -14.62M -8.91M -4.09M 3.31M
Cash 3.77M 0.42M 0.33M 0.35M 1.51M
Total current liabilities 1.08M 1.47M 1.91M 1.23M 1.31M
Net debt 0.74M - - 0.24M -
Short long term debt 0.47M 0.02M 0.01M 0.59M -
Other stockholder equity 6.25M 3.74M 1.96M 1.45M 0.37M
Property plant equipment 0.25M 0.31M 0.05M 0.08M 1.50M
Total current assets 4.68M 1.76M 1.71M 3.26M 2.70M
Net tangible assets - 0.35M -0.22M 2.11M 2.88M
Net receivables 0.45M 0.61M 0.06M 1.41M 0.58M
Long term debt 4.03M 0.05M 0.07M - -
Inventory 0.46M 0.64M 1.24M 1.17M -
Accounts payable 0.42M 0.73M 0.66M 0.11M 0.15M
Non current assets total 1.46M 1.50M 0.05M 0.08M 4.94M
Capital lease obligations 0.22M 0.27M - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -0.64M -0.64M 0.30M -0.16M 2.79M
Change to liabilities 0.00M 0.07M -0.24M -0.42M -1.40M
Total cashflows from investing activities - -0.64M 0.30M -0.16M 2.79M
Net borrowings 4.61M -0.06M 0.08M -0.86M -0.86M
Total cash from financing activities 6.61M 5.64M 0.62M 1.25M 1.66M
Change to operating activities - -1.20M 1.24M 1.24M 1.24M
Net income -4.29M -5.71M -5.95M -7.08M -5.77M
Change in cash 3.35M 0.09M -0.02M -1.16M 0.91M
Begin period cash flow 0.42M 0.33M 0.35M 1.51M 0.60M
End period cash flow 3.77M 0.42M 0.33M 0.35M 1.51M
Total cash from operating activities -2.51M -4.96M -0.98M -2.26M -3.57M
Issuance of capital stock 2.00M 5.70M 0.54M 2.11M 1.66M
Depreciation 0.13M 0.11M 0.02M 0.33M 0.32M
Change to inventory -0.03M -0.06M -0.28M -1.17M -1.17M
Change to account receivables 0.29M -0.56M 1.30M 0.94M 1.35M
Other cashflows from financing activities 2.00M -0.05M 0.30M -0.16M 2.79M
Change to netincome 1.62M 2.39M 1.81M 6.23M 1.93M
Capital expenditures 0.64M 0.64M 0.00M 0.16M 1.45M
Change in working capital 0.02M -1.76M 2.03M -0.64M -0.05M
Stock based compensation 1.17M 2.05M 1.41M 1.14M 0.00M
Other non cash items 0.45M 0.09M 0.40M 5.10M 1.93M
Free cash flow -3.15M -5.61M -0.99M -2.42M -5.02M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
0.03
0.09%
33.71 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-0.54
0.32%
168.71 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-
-%
20.87 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
4.63
12.39%
42.00 - 10.66 0.01 1.16 2.94 23.11

Profile*

Chill Brands Group PLC

Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.

Eastcastle House, London, United Kingdom, W1W 8DH

7

Name Title Year Born
Mr. Trevor Taylor Founder, COO & Exec. Director NA
Mr. Antonio Russo Founder, Chief Commercial Officer & Exec. Director NA
Mr. Callum Sommerton CEO & Exec. Director NA
Mr. Paul Ferguson CFO & Director NA
Mr. Will Aspinwall Internal Counsel and Bus. Devel. NA
Mr. Graham John William Duncan Finance Director & Director 1963
Mr. Will Aspinwall Internal Counsel and Business Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…